PARP Inhibitors: Targeting the Right Patients

被引：1
|
作者：
Azvolinsky, Anna
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 24期
关键词：
D O I：
10.1093/jnci/djs514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1851 / +
页数：2
相关论文
共 50 条
  • [1] Targeting PARP inhibitor resistance with Polθ inhibitors
    Zatreanu, Diana
    Robinson, Helen
    Alkhatib, Omar
    Boursier, Marie
    Finch, Harry
    Geo, Lerin
    Grande, Diego
    Grinkevich, Vera
    Heald, Robert
    Langdon, Sophie
    Majithiya, Jayesh
    McWhirter, Claire
    Martin, Niall
    Moore, Shaun
    Neves, Joana
    Rajendra, Eeson
    Ranzani, Marco
    Schaedler, Theresia
    Stockley, Martin
    Wiggins, Kimberley
    Brough, Rachel
    Sridhar, Sandhya
    Gulati, Aditi
    Shao, Nan
    Badder, Luted
    Novo, Daniela
    Knight, Eleanor
    Marlow, Rebecca
    Haider, Syed
    Callen, Elsa
    Hewitt, Graeme
    Schimmel, Joost
    Prevo, Remko
    Alli, Christina
    Ferdinand, Amanda
    Bell, Cameron
    Blencowe, Peter
    Bot, Chris
    Calder, Mathew
    Charles, Mark
    Curry, Jayne
    Ekwuru, Tennyson
    Nussenzweig, Andre
    Tijsterman, Marcel
    Tutt, Andrew N.
    Boulton, Simon
    Higgins, Geoff
    Pettitt, Stephen J.
    Smith, Graeme C.
    Lord, Christopher J.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [2] Targeting DNA Repair in Cancer : Beyond PARP Inhibitors
    Brown, Jessica S.
    O'Carrigan, Brent
    Jackson, Stephen P.
    Yap, Timothy A.
    [J]. CANCER DISCOVERY, 2017, 7 (01) : 20 - 37
  • [3] NOVEL MOLECULAR TARGETING AND RADIATION - CLINICAL UPDATE: PARP INHIBITORS
    Chalmers, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S7 - S7
  • [4] Targeting homologous recombination: Translational studies of CDK and PARP inhibitors
    Shapiro, G. I.
    [J]. CANCER RESEARCH, 2013, 73
  • [5] Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
    Mendes-Pereira, Ana M.
    Martin, Sarah A.
    Brough, Rachel
    McCarthy, Afshan
    Taylor, Jessica R.
    Kim, Jung-Sik
    Waldman, Todd
    Lord, Christopher J.
    Ashworth, Alan
    [J]. EMBO MOLECULAR MEDICINE, 2009, 1 (6-7) : 315 - 322
  • [6] Targeting Glioblastoma Stem Cells with Oncolytic HSV and PARP Inhibitors
    Ning, Jianfang
    Wakimoto, Hiroaki
    Martuza, Robert L.
    Rabkin, Samuel D.
    [J]. MOLECULAR THERAPY, 2014, 22 : S68 - S68
  • [7] Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors
    Yelamos, Jose
    Galindo, Miguel
    Navarro, Judith
    Albanell, Joan
    Rovira, Ana
    Rojo, Federico
    Oliver, Javier
    [J]. ONCOIMMUNOLOGY, 2016, 5 (01):
  • [8] Cardiotoxicity in patients treated with PARP-inhibitors
    Blanco Clemente, M.
    Martinez Cutillas, M.
    Garitaonaindia Diaz, Y.
    Mitroi, C. D.
    Nunez Garcia, B.
    Mendez, M.
    Sanchez Gonzalez, J. C.
    B. Cantos Sanchez De Ibarguen
    Gonzalez Del Alba, A.
    Menchen Viso, B.
    Provencio Pulla, M.
    Maximiano Alonso, C.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S743 - S743
  • [9] PARP inhibitors
    Liang H.
    Tan A.R.
    [J]. Current Breast Cancer Reports, 2011, 3 (1) : 44 - 54
  • [10] PARP inhibitors
    Maheen Anwar
    Hafiz Muhammad Aslam
    Shahzad Anwar
    [J]. Hereditary Cancer in Clinical Practice, 13
12345